ACE Reports.
Make a selection below to explore our full database of 2 results on the topic: "B Mihov"
ACE Reports
(2 Reports)ACE Reports
(2 Reports)
Metabolic Disorders
Significant reduction in 6-year fragility fracture risk with zoledronate vs placebo for osteopenia
N Engl J Med. 2018 Dec 20;379(25):2407-2416. doi: 10.1056/NEJMoa1808082
.jpg)
General Orthopaedics
Effects of 2.5mg zoledronate are long-lasting and similar to 5mg dose in osteopenic women
J Bone Miner Res. 2014 Jan;29(1):166-72. doi: 10.1002/jbmr.2009.